DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Chen S, Zhao X, Wan J. et al.
Dihydromyricetin improves glucose and lipid metabolism and exerts
anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized
controlled trial.
Pharmacol Res 2015;
99: 74-81
We do not assume any responsibility for the contents of the web pages of other providers.